This study investigates advanced pancreatic cancer. It uses a unique approach with intratumoral diffusing alpha radiation emitters.
The purpose of this study is to evaluate the feasibility and safety of the investigational treatment. It focuses on understanding how the treatment works in patients with advanced pancreatic cancer.
- Who can participate: Adults aged 18 and older with pancreatic cancer may participate.
- Study details: Participants will undergo a procedure to insert the investigational treatment into the tumor. They will be monitored for safety and effectiveness over three months.
- Study timelines: The study will last 3 months.